Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
Anaerobe. 2021 Dec;72:102448. doi: 10.1016/j.anaerobe.2021.102448. Epub 2021 Sep 17.
To perform surveillance of cfiA-positive Bacteroides fragilis using new subtyping software module, MALDI Biotyper Subtyping Module (MBT Subtyping Module), on MALDI-TOF MS system, and to evaluate the detection ability of the module.
cfiA-positive strains were presumed using the module against B. fragilis isolated between 2006 and 2019. The cfiA gene was confirmed using PCR. In cfiA-positive B. fragilis, the insertion sequence (IS) elements were examined and the MBT STAR-BL assay was performed to examine meropenem hydrolysis activity.
Of the 396 B. fragilis strains included, the MBT Subtyping Module detected 33 presumptive cfiA-positive strains (8.3%), of which 32 harbored the cfiA gene. The sensitivity and specificity of the MBT Subtyping Module for detecting cfiA-positive B. fragilis were 100.0% and 99.7%, respectively. Of the 32 strains harboring the cfiA gene, seven strains possessed IS elements, which were thought to induce high cfiA expression. Meropenem hydrolysis was detected in all seven strains that were positive for both cfiA and IS elements, and they exhibited resistance to meropenem and imipenem. The overall non-susceptibility rates to meropenem and imipenem were 84.8% and 36.4%, respectively, in the 33 presumptive cfiA-positive strains.
The MBT Subtyping Module can detect cfiA-positive B. fragilis rapidly and accurately, supporting its use for surveillance of cfiA-positive B. fragilis in clinical settings.
使用 MALDI-TOF MS 系统上的新型分型软件模块 MALDI Biotyper 分型模块(MBT 分型模块)对 cfiA 阳性脆弱拟杆菌进行监测,并评估该模块的检测能力。
针对 2006 年至 2019 年分离的脆弱拟杆菌,使用该模块推测 cfiA 阳性菌株。使用 PCR 确认 cfiA 基因。在 cfiA 阳性脆弱拟杆菌中,检查插入序列(IS)元件,并进行 MBT STAR-BL 检测以检查美罗培南水解活性。
在纳入的 396 株脆弱拟杆菌中,MBT 分型模块检测到 33 株推定 cfiA 阳性菌株(8.3%),其中 32 株携带 cfiA 基因。MBT 分型模块检测 cfiA 阳性脆弱拟杆菌的敏感性和特异性分别为 100.0%和 99.7%。携带 cfiA 基因的 32 株菌株中,有 7 株菌株携带 IS 元件,这些元件可能诱导 cfiA 高表达。在同时携带 cfiA 和 IS 元件的 7 株阳性菌株中均检测到美罗培南水解,它们对美罗培南和亚胺培南表现出耐药性。在 33 株推定 cfiA 阳性菌株中,对美罗培南和亚胺培南的总不敏感性率分别为 84.8%和 36.4%。
MBT 分型模块可以快速准确地检测 cfiA 阳性脆弱拟杆菌,支持其在临床环境中用于脆弱拟杆菌 cfiA 阳性的监测。